Immediate Impact
54 standout
Citing Papers
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
2024 Standout
Works of Heqing Yi being referenced
miR‑221‑3p and miR‑222‑3p regulate the SOCS3/STAT3 signaling pathway to downregulate the expression of NIS and reduce radiosensitivity in thyroid cancer
2021
The role and mechanism of autophagy in sorafenib targeted cancer therapy
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Heqing Yi | 67 | 108 | 58 | 209 | 151 | 23 | 408 | |
| Kristy Kwan‐Shuen Chan | 77 | 83 | 20 | 246 | 119 | 19 | 454 | |
| Lifang Wu | 39 | 55 | 36 | 185 | 105 | 23 | 414 | |
| Xiaodi Yan | 44 | 72 | 25 | 270 | 130 | 28 | 400 | |
| Nong Li | 54 | 112 | 38 | 182 | 92 | 24 | 389 | |
| Yunwei Guo | 58 | 106 | 30 | 224 | 168 | 27 | 433 | |
| Guohe Song | 132 | 112 | 49 | 208 | 140 | 19 | 457 | |
| Brigitte Simon | 104 | 32 | 26 | 193 | 113 | 19 | 411 | |
| Mingzhi Xie | 153 | 45 | 45 | 178 | 83 | 28 | 426 | |
| Yixuan Sun | 75 | 80 | 23 | 178 | 94 | 23 | 447 | |
| Shenghui Qin | 105 | 37 | 27 | 289 | 153 | 26 | 458 |
All Works
Login with ORCID to disown or claim papers
Loading papers...